Back
Applied Therapeutics 10K Form
Sell
29
APLT
Applied Therapeutics
Last Price:
$0.86
Seasonality Move:
5.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-11 | 10Q | APLT/Applied Therapeutics Quarterly |
| 2020-05-11 | 10Q | APLT/Applied Therapeutics Quarterly |
| 2020-03-13 | 10K | APLT/Applied Therapeutics Annual |
| 2019-11-13 | 10Q | APLT/Applied Therapeutics Quarterly |
| 2019-08-12 | 10Q | APLT/Applied Therapeutics Quarterly |
| 2019-06-21 | 10Q | APLT/Applied Therapeutics Quarterly |
Receive APLT News And Ratings
See the #1 stock for the next 7 days that we like better than APLT
APLT Financial Statistics
Sales & Book Value
| Annual Sales: | $10M |
|---|---|
| Cash Flow: | $-23.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.05 |
| Price / Book: | 17.12 |
Profitability
| EPS (TTM): | -1.61000 |
|---|---|
| Net Income (TTM): | $-187.3M |
| Gross Margin: | -- |
| Return on Equity: | -797.82% |
| Return on Assets: | -192.86% |
Applied Therapeutics Earnings Forecast
Key Applied Therapeutics Financial Ratios
-
The Research & Development expenses have been 539.43% of Revenue.
-
The Net Earning history of APLT is -1,198.47% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 3 years.
Applied Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | APLT |
| CUSIP: | 03828A |
| Website: | appliedtherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.06 |
| Quick Ratio: | 1 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
APLT Technical Analysis vs Fundamental Analysis
Sell
29
Applied Therapeutics (APLT)
is a Sell
Is Applied Therapeutics a Buy or a Sell?
-
Applied Therapeutics stock is rated a SellThe current Applied Therapeutics [APLT] share price is $0.87. The Score for APLT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.